Posted by Michael Wonder on 21 Sep 2020
Pear Therapeutics and PreferredOne announce broad based patient access and reimbursement for reSET & reSET-O for people with substance use disorder and opioid use disorder
21 September 2020 - PreferredOne teams with Pear to provide its members with covered access to two prescription digital therapeutics for the treatment of substance use disorder and opioid use disorder.
Pear Therapeutics and PreferredOne announced today that reSET and reSET-O, the first two prescription digital therapeutics to receive authorisation to treat disease from the U.S. FDA, have been added to PreferredOne’s medical benefits as covered products for its members.
PreferredOne, a wholly-owned subsidiary of Fairview Health Services, leads the market with products and services that conserve employer health plan dollars while helping more than 364,000 members achieve their best health.
